These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

498 related articles for article (PubMed ID: 20610717)

  • 21. Immunization with SARS-CoV S DNA vaccine generates memory CD4+ and CD8+ T cell immune responses.
    Huang J; Ma R; Wu CY
    Vaccine; 2006 Jun; 24(23):4905-13. PubMed ID: 16621188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Humoral and cellular immune responses induced by 3a DNA vaccines against severe acute respiratory syndrome (SARS) or SARS-like coronavirus in mice.
    Lu B; Tao L; Wang T; Zheng Z; Li B; Chen Z; Huang Y; Hu Q; Wang H
    Clin Vaccine Immunol; 2009 Jan; 16(1):73-7. PubMed ID: 18987164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Enhanced induction of SARS-CoV nucleocapsid protein-specific immune response using DNA vaccination followed by adenovirus boosting in BALB/c mice.
    Chunling M; Kun Y; Jian X; Jian Q; Hua S; Minsheng Z
    Intervirology; 2006; 49(5):307-18. PubMed ID: 16809936
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of vaccines and passive immunotherapy against SARS coronavirus using mouse and SCID-PBL/hu mouse models.
    Okada M; Takemoto Y; Okuno Y; Hashimoto S; Fukunaga Y; Tanaka T; Kita Y; Kuwayama S; Muraki Y; Kanamaru N; Takai H; Okada C; Sakaguchi Y; Furukawa I; Yamada K; Izumiya M; Yoshida S; Matsumoto M; Kase T; Peiris JS; DeMello DE; Chen PJ; Yamamoto N; Yoshinaka Y; Nomura T; Ishida I; Morikawa S; Tashiro M; Sakatani M
    Adv Exp Med Biol; 2006; 581():561-6. PubMed ID: 17037598
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice.
    Glass WG; Subbarao K; Murphy B; Murphy PM
    J Immunol; 2004 Sep; 173(6):4030-9. PubMed ID: 15356152
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of mucosal and systemic immunization with virus-like particles of severe acute respiratory syndrome coronavirus in mice.
    Lu B; Huang Y; Huang L; Li B; Zheng Z; Chen Z; Chen J; Hu Q; Wang H
    Immunology; 2010 Jun; 130(2):254-61. PubMed ID: 20406307
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS.
    Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N
    Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Receptor-binding domain of SARS-CoV spike protein induces long-term protective immunity in an animal model.
    Du L; Zhao G; He Y; Guo Y; Zheng BJ; Jiang S; Zhou Y
    Vaccine; 2007 Apr; 25(15):2832-8. PubMed ID: 17092615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative evaluation of two severe acute respiratory syndrome (SARS) vaccine candidates in mice challenged with SARS coronavirus.
    See RH; Zakhartchouk AN; Petric M; Lawrence DJ; Mok CPY; Hogan RJ; Rowe T; Zitzow LA; Karunakaran KP; Hitt MM; Graham FL; Prevec L; Mahony JB; Sharon C; Auperin TC; Rini JM; Tingle AJ; Scheifele DW; Skowronski DM; Patrick DM; Voss TG; Babiuk LA; Gauldie J; Roper RL; Brunham RC; Finlay BB
    J Gen Virol; 2006 Mar; 87(Pt 3):641-650. PubMed ID: 16476986
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cell-mediated immune response to respiratory coronaviruses.
    Channappanavar R; Zhao J; Perlman S
    Immunol Res; 2014 Aug; 59(1-3):118-28. PubMed ID: 24845462
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of protective immunity against severe acute respiratory syndrome coronavirus (SARS-CoV) infection using highly attenuated recombinant vaccinia virus DIs.
    Ishii K; Hasegawa H; Nagata N; Mizutani T; Morikawa S; Suzuki T; Taguchi F; Tashiro M; Takemori T; Miyamura T; Tsunetsugu-Yokota Y
    Virology; 2006 Aug; 351(2):368-80. PubMed ID: 16678878
    [TBL] [Abstract][Full Text] [Related]  

  • 32. T-cell immunity of SARS-CoV: Implications for vaccine development against MERS-CoV.
    Liu WJ; Zhao M; Liu K; Xu K; Wong G; Tan W; Gao GF
    Antiviral Res; 2017 Jan; 137():82-92. PubMed ID: 27840203
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lack of innate interferon responses during SARS coronavirus infection in a vaccination and reinfection ferret model.
    Cameron MJ; Kelvin AA; Leon AJ; Cameron CM; Ran L; Xu L; Chu YK; Danesh A; Fang Y; Li Q; Anderson A; Couch RC; Paquette SG; Fomukong NG; Kistner O; Lauchart M; Rowe T; Harrod KS; Jonsson CB; Kelvin DJ
    PLoS One; 2012; 7(9):e45842. PubMed ID: 23029269
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein.
    Zhi Y; Kobinger GP; Jordan H; Suchma K; Weiss SR; Shen H; Schumer G; Gao G; Boyer JL; Crystal RG; Wilson JM
    Virology; 2005 Apr; 335(1):34-45. PubMed ID: 15823604
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T cell responses to whole SARS coronavirus in humans.
    Li CK; Wu H; Yan H; Ma S; Wang L; Zhang M; Tang X; Temperton NJ; Weiss RA; Brenchley JM; Douek DC; Mongkolsapaya J; Tran BH; Lin CL; Screaton GR; Hou JL; McMichael AJ; Xu XN
    J Immunol; 2008 Oct; 181(8):5490-500. PubMed ID: 18832706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Utility of the aged BALB/c mouse model to demonstrate prevention and control strategies for severe acute respiratory syndrome coronavirus (SARS-CoV).
    Vogel LN; Roberts A; Paddock CD; Genrich GL; Lamirande EW; Kapadia SU; Rose JK; Zaki SR; Subbarao K
    Vaccine; 2007 Mar; 25(12):2173-9. PubMed ID: 17227689
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Adenovirus-based vaccine prevents pneumonia in ferrets challenged with the SARS coronavirus and stimulates robust immune responses in macaques.
    Kobinger GP; Figueredo JM; Rowe T; Zhi Y; Gao G; Sanmiguel JC; Bell P; Wivel NA; Zitzow LA; Flieder DB; Hogan RJ; Wilson JM
    Vaccine; 2007 Jul; 25(28):5220-31. PubMed ID: 17559989
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-spike IgG causes severe acute lung injury by skewing macrophage responses during acute SARS-CoV infection.
    Liu L; Wei Q; Lin Q; Fang J; Wang H; Kwok H; Tang H; Nishiura K; Peng J; Tan Z; Wu T; Cheung KW; Chan KH; Alvarez X; Qin C; Lackner A; Perlman S; Yuen KY; Chen Z
    JCI Insight; 2019 Feb; 4(4):. PubMed ID: 30830861
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential virological and immunological outcome of severe acute respiratory syndrome coronavirus infection in susceptible and resistant transgenic mice expressing human angiotensin-converting enzyme 2.
    Yoshikawa N; Yoshikawa T; Hill T; Huang C; Watts DM; Makino S; Milligan G; Chan T; Peters CJ; Tseng CT
    J Virol; 2009 Jun; 83(11):5451-65. PubMed ID: 19297479
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A double-inactivated whole virus candidate SARS coronavirus vaccine stimulates neutralising and protective antibody responses.
    Spruth M; Kistner O; Savidis-Dacho H; Hitter E; Crowe B; Gerencer M; Brühl P; Grillberger L; Reiter M; Tauer C; Mundt W; Barrett PN
    Vaccine; 2006 Jan; 24(5):652-61. PubMed ID: 16214268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.